APEI Just Raised Guidance While Warning That Next Quarter Will Be the Worst

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

APEI typically reports earnings after market close, meaning Day 0 reflects anticipation before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

APEI's post-earnings price action has been highly volatile, with an average absolute Day 0 move of 4.25% and Day +1 move of 10.76%. The Day +1 range averages 13.87%, indicating substantial two-way volatility as the market digests results.

The most recent earnings (August 2026) saw a sharp 7.51% decline on Day 0, followed by a 3.52% drop on Day +1, despite the company beating estimates and raising guidance. This suggests profit-taking after a strong run-up or concerns about the Q3 outlook. In contrast, the March 2026 report produced a 21.19% surge on Day +1, one of the largest reactions in the dataset, reflecting the market's enthusiasm for the Q1 beat and raised guidance.

The pattern shows that APEI tends to see its largest moves on Day +1 rather than Day 0, consistent with after-hours reporting. The direction of moves has been mixed, with four positive and four negative Day +1 reactions over the past eight quarters, though the magnitude of positive moves (particularly in March and November 2025) has been larger than the negative ones. Investors should expect significant volatility following this release, particularly given the sharp deceleration in the EPS estimate and the market's sensitivity to guidance commentary around military enrollment and Health+ recovery.

Part 2.2: Options Market Expected Move

The options market is pricing a 16.88% expected move for APEI through the November 20 expiration, significantly higher than the stock's average historical Day +1 move of 10.76% and Day +1 range of 13.87%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction to this earnings release, possibly reflecting uncertainty around the sustainability of APEI's recent outperformance and the impact of military deployment headwinds on Q3 results.

Part 3: What Analysts Are Saying

Analysts maintain a strongly bullish stance on APEI, with 7 Strong Buy ratings and 2 Hold ratings among 9 analysts covering the stock. The average recommendation of 4.56 out of 5.0 reflects high conviction in the company's turnaround story and growth prospects. This consensus has remained unchanged over the past month, indicating stable sentiment heading into the Q3 report.

The average price target of $61.62 implies 65.3% upside from the current price of $37.28, with estimates ranging from a low of $52.00 to a high of $69.00. This wide range reflects differing views on the pace of margin expansion and the sustainability of enrollment growth, particularly in the Health+ segment.

Analysts have raised price targets throughout 2026 following better-than-expected execution. Multiple firms lifted targets into the low-to-mid $60s after Q1 and Q2 beats, citing resilient Military+ performance, Health+ recovery, and margin expansion potential. However, some analysts have adopted a more cautious tone, suggesting that the recent strength in shares already incorporates much of the 2026 upside scenario and that valuation support depends on continued solid execution on registrations and margin improvement. The consensus view remains constructive, but with limited room for disappointment given the elevated expectations embedded in both the stock price and analyst models.

Part 4: Technical Picture

APEI's technical setup heading into earnings is decidedly weak. The Barchart Technical Opinion currently shows an 88% Sell signal, unchanged from last week but significantly deteriorated from 40% Sell a month ago. This sharp shift reflects mounting technical pressure as the stock has broken below key support levels.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative
• Medium-term (100% Sell): Strong sell signal suggests consolidation and weakness in the intermediate timeframe
• Long-term (100% Sell): Strong sell signal reflects deterioration in the longer-term trend

The trend is characterized by Strong strength in the Strongest direction—in this case, strongly to the downside. This suggests intensifying selling pressure across all timeframes, creating a challenging technical environment heading into the earnings release.

The stock is trading at $37.28, below all major moving averages: the 5-day ($40.37), 10-day ($42.46), 20-day ($45.56), 50-day ($44.80), 100-day ($47.79), and 200-day ($49.71). This complete breakdown below all moving averages is a significant technical red flag, indicating that the stock has lost support at every meaningful timeframe. The downward slope of the moving averages confirms a deteriorating trend structure. From a technical perspective, APEI enters earnings in a vulnerable position, with no nearby support levels and all momentum indicators pointing lower. A strong earnings beat and positive guidance would be needed to reverse this technical damage and reclaim key moving averages.